<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34021780</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2013</ISSN><JournalIssue CitedMedium="Internet"><Volume>473</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Pflugers Archiv : European journal of physiology</Title><ISOAbbreviation>Pflugers Arch</ISOAbbreviation></Journal><ArticleTitle>Clenbuterol-sensitive delayed outward potassium currents in a cell model of spinal and bulbar muscular atrophy.</ArticleTitle><Pagination><StartPage>1213</StartPage><EndPage>1227</EndPage><MedlinePgn>1213-1227</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00424-021-02559-6</ELocationID><Abstract><AbstractText>Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disease caused by polyglutamine (polyQ) expansions in the androgen receptor (AR) gene. SBMA is characterized by selective dysfunction and degeneration of motor neurons in the brainstem and spinal cord through still unclear mechanisms in which ion channel modulation might play a central role as for other neurodegenerative diseases. The beta2-adrenergic agonist clenbuterol was observed to ameliorate the SBMA phenotype in mice and patient-derived myotubes. However, the underlying molecular mechanism has yet to be clarified. Here, we unveil that ionic current alterations induced by the expression of polyQ-expanded AR in motor neuron-derived MN-1 cells are attenuated by the administration of clenbuterol. Our combined electrophysiological and pharmacological approach allowed us to reveal that clenbuterol modifies delayed outward potassium currents. Overall, we demonstrated that the protection provided by clenbuterol restores the normal function through the modulation of K<sub>V</sub>2-type outward potassium currents, possibly contributing to the protective effect on motor neuron toxicity in SBMA.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mart&#xed;nez-Rojas</LastName><ForeName>Vladimir A</ForeName><Initials>VA</Initials><Identifier Source="ORCID">0000-0002-3155-8096</Identifier><AffiliationInfo><Affiliation>Institute of Biophysics (IBF), Trento Unit, National Research Council (CNR) &amp; LabSSAH, Bruno Kessler Foundation (FBK), Trento, Italy. vlalx.mr@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arosio</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2872-6906</Identifier><AffiliationInfo><Affiliation>Institute of Biophysics (IBF), Trento Unit, National Research Council (CNR) &amp; LabSSAH, Bruno Kessler Foundation (FBK), Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pennuto</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8634-0767</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DSB), University of Padova, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center (PNC), University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musio</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2106-9931</Identifier><AffiliationInfo><Affiliation>Institute of Biophysics (IBF), Trento Unit, National Research Council (CNR) &amp; LabSSAH, Bruno Kessler Foundation (FBK), Trento, Italy. carlo.musio@cnr.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 NS111768</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Pflugers Arch</MedlineTA><NlmUniqueID>0154720</NlmUniqueID><ISSNLinking>0031-6768</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D060829">Arthropod Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051668">Delayed Rectifier Potassium Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C550903">GxTX-1E, Plesiophrictus guangxiensis</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013111">Spider Venoms</NameOfSubstance></Chemical><Chemical><RegistryNumber>XTZ6AXU7KN</RegistryNumber><NameOfSubstance UI="D002976">Clenbuterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060829" MajorTopicYN="N">Arthropod Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002976" MajorTopicYN="N">Clenbuterol</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051668" MajorTopicYN="N">Delayed Rectifier Potassium Channels</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018408" MajorTopicYN="N">Patch-Clamp Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013111" MajorTopicYN="N">Spider Venoms</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clenbuterol</Keyword><Keyword MajorTopicYN="N">Ion channels</Keyword><Keyword MajorTopicYN="N">Kv2 potassium channels</Keyword><Keyword MajorTopicYN="N">Outward ionic currents</Keyword><Keyword MajorTopicYN="N">PolyQ AR MN-1 cells</Keyword><Keyword MajorTopicYN="N">Spinal and bulbar muscular atrophy (SBMA)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>22</Day><Hour>12</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34021780</ArticleId><ArticleId IdType="doi">10.1007/s00424-021-02559-6</ArticleId><ArticleId IdType="pii">10.1007/s00424-021-02559-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akita T, Fukuda A (2020) Intracellular Cl<sup>-</sup> dysregulation causing and caused by pathogenic neuronal activity. Pflugers Arch - Eur J Physiol 472:977&#x2013;987. https://doi.org/10.1007/s00424-020-02375-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-020-02375-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariano MA, Cepeda C, Calvert CR, Flores-Hern&#xe1;ndez J, Hern&#xe1;ndez-Echeagaray E, Klapstein GJ, Chandler SH, Aronin N, DiFiglia M, Levine MS (2005) Striatal potassium channel dysfunction in Huntington&#x2019;s disease transgenic mice. J Neurophysiol 93:2565&#x2013;2574. https://doi.org/10.1152/jn.00791.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00791.2004</ArticleId><ArticleId IdType="pubmed">15625098</ArticleId></ArticleIdList></Reference><Reference><Citation>Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG, Han LY, Mangala LS, Villares GJ, Vivas-Mejia P, Rodriguez-Aguayo C, Nagaraja AS, Gharpure KM, Wu Z, English RD, Soman KV, Shahzad MMK, Zigler M, Deavers MT, Zien A, Soldatos TG, Jackson DB, Wiktorowicz JE, Torres-Lugo M, Young T, De Geest K, Gallick GE, Bar-Eli M, Lopez-Berestein G, Cole SW, Lopez GE, Lutgendorf SK, Sood AK (2013) Src activation by adrenoreceptors is a key switch for tumour metastasis. Nat Commun 4:1&#x2013;12. https://doi.org/10.1038/ncomms2413</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2413</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashcroft FM (2006) From molecule to malady. Nature 440:440&#x2013;447. https://doi.org/10.1038/nature04707</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04707</ArticleId><ArticleId IdType="pubmed">16554803</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Peng H, Etlinger JD, Zeman RJ (2010) Partial functional recovery after complete spinal cord transection by combined chondroitinase and clenbuterol treatment. Pflugers Arch - Eur J Physiol 460:657&#x2013;666. https://doi.org/10.1007/s00424-010-0852-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-010-0852-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Bushart DD, Shakkottai VG (2019) Ion channel dysfunction in cerebellar ataxia. Neurosci Lett 688:41&#x2013;48. https://doi.org/10.1016/j.neulet.2018.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.02.005</ArticleId><ArticleId IdType="pubmed">29421541</ArticleId></ArticleIdList></Reference><Reference><Citation>Bushart DD, Chopra R, Singh V, Murphy GG, Wulff H, Shakkottai VG (2018) Targeting potassium channels to treat cerebellar ataxia. Ann Clin Transl Neurol 5:297&#x2013;314. https://doi.org/10.1002/acn3.527</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.527</ArticleId><ArticleId IdType="pubmed">29560375</ArticleId><ArticleId IdType="pmc">5846455</ArticleId></ArticleIdList></Reference><Reference><Citation>Bushart DD, Huang H, Man LJ, Morrison LM, Shakkottai VG (2020) A chlorzoxazone-baclofen combination improves cerebellar impairment in spinocerebellar ataxia type 1. Mov Disord. https://doi.org/10.1002/mds.28355</Citation></Reference><Reference><Citation>Cao XH, Byun HS, Chen SR, Cai YQ, Pan HL (2010) Reduction in voltage-gated K+ channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain-derived neurotrophic factor. J Neurochem 114:1460&#x2013;1475. https://doi.org/10.1111/j.1471-4159.2010.06863.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06863.x</ArticleId><ArticleId IdType="pubmed">20557422</ArticleId><ArticleId IdType="pmc">2923276</ArticleId></ArticleIdList></Reference><Reference><Citation>Catacuzzeno L, Sforna L, Franciolini F (2020) Voltage-dependent gating in K channels: experimental results and quantitative models. Pflugers Arch - Eur J Physiol 472:27&#x2013;47. https://doi.org/10.1007/s00424-019-02336-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-019-02336-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra R, Shakkottai VG (2014) The role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders. Neurotherapeutics 11:751&#x2013;763. https://doi.org/10.1007/s13311-014-0289-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-014-0289-7</ArticleId><ArticleId IdType="pubmed">24986674</ArticleId><ArticleId IdType="pmc">4391381</ArticleId></ArticleIdList></Reference><Reference><Citation>Deardorff AS, Romer SH, Sonner PM, Fyffe REW (2014) Swimming against the tide: investigations of the C-bouton synapse. Front Neural Circuits 8:106. https://doi.org/10.3389/fncir.2014.00106</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncir.2014.00106</ArticleId><ArticleId IdType="pubmed">25278842</ArticleId><ArticleId IdType="pmc">4167003</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Ram&#xed;rez M, De Jes&#xfa;s-P&#xe9;rez JJ, Ar&#xe9;chiga-Figueroa IA, Arreola J, Adney SK, Villalba-Galea CA, Logothetis DE, Rodr&#xed;guez-Menchaca AA (2018) Regulation of Kv2.1 channel inactivation by phosphatidylinositol 4,5-bisphosphate. Sci Rep 8:1&#x2013;13. https://doi.org/10.1038/s41598-018-20280-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20280-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell&#x2019;Orco JM, Pulst SM, Shakkottai VG (2017) Potassium channel dysfunction underlies Purkinje neuron spiking abnormalities in spinocerebellar ataxia type 2. Hum Mol Genet 26:3935&#x2013;3945. https://doi.org/10.1093/hmg/ddx281</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx281</ArticleId><ArticleId IdType="pubmed">29016852</ArticleId><ArticleId IdType="pmc">5886219</ArticleId></ArticleIdList></Reference><Reference><Citation>Desaphy JF, Pierno S, De Luca A, Didonna P, Camerino DC (2003) Different ability of clenbuterol and salbutamol to block sodium channels predicts their therapeutic use in muscle excitability disorders. Mol Pharmacol 63:659&#x2013;670. https://doi.org/10.1124/mol.63.3.659</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.63.3.659</ArticleId><ArticleId IdType="pubmed">12606775</ArticleId></ArticleIdList></Reference><Reference><Citation>Deutsch E, Weigel AV, Akin EJ, Fox P, Hansen G, Haberkorn CJ, Loftus R, Krapf D, Tamkun MM (2012) Kv2.1 cell surface clusters are insertion platforms for ion channel delivery to the plasma membrane. Mol Biol Cell 23:2917&#x2013;2929. https://doi.org/10.1091/mbc.E12-01-0047</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E12-01-0047</ArticleId><ArticleId IdType="pubmed">22648171</ArticleId><ArticleId IdType="pmc">3408418</ArticleId></ArticleIdList></Reference><Reference><Citation>Egorova PA, Gavrilova AV, Bezprozvanny IB (2020) Ataxic symptoms in Huntington&#x2019;s disease transgenic mouse model are alleviated by chlorzoxazone. Front Neurosci 14:279. https://doi.org/10.3389/fnins.2020.00279</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00279</ArticleId><ArticleId IdType="pubmed">32317916</ArticleId><ArticleId IdType="pmc">7147686</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher EV, Simon CM, Pagiazitis JG, Chalif JI, Vukojicic A, Drobac E, Wang X, Mentis GZ (2017) Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy. Nat Neurosci 20:905&#x2013;916. https://doi.org/10.1038/nn.4561</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4561</ArticleId><ArticleId IdType="pubmed">28504671</ArticleId><ArticleId IdType="pmc">5487291</ArticleId></ArticleIdList></Reference><Reference><Citation>Frerichs O, Fansa H, Ziems P, Schneider W, Keilhoff G (2001) Regeneration of peripheral nerves after clenbuterol treatment in a rat model. Muscle Nerve 24:1687&#x2013;1691. https://doi.org/10.1002/mus.10006</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10006</ArticleId><ArticleId IdType="pubmed">11745978</ArticleId></ArticleIdList></Reference><Reference><Citation>Gayet-Primo J, Yaeger DB, Khanjian RA, Puthussery T (2018) Heteromeric KV2/KV8.2 channels mediate delayed rectifier potassium currents in primate photoreceptors. J Neurosci 38:3414&#x2013;3427. https://doi.org/10.1523/JNEUROSCI.2440-17.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2440-17.2018</ArticleId><ArticleId IdType="pubmed">29483285</ArticleId><ArticleId IdType="pmc">5895036</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromova A, La Spada AR (2020) Harmony lost: cell&#x2013;cell communication at the neuromuscular junction in motor neuron disease. Trends Neurosci 43:709&#x2013;724. https://doi.org/10.1016/j.tins.2020.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2020.07.002</ArticleId><ArticleId IdType="pubmed">32846148</ArticleId></ArticleIdList></Reference><Reference><Citation>Halievski K, Nath SR, Katsuno M, Adachi H, Sobue G, Breedlove SM, Lieberman AP, Jordan CL (2019) Disease affects BDNF expression in synaptic and extrasynaptic regions of skeletal muscle of three SBMA mouse models. Int J Mol Sci 20:1&#x2013;19. https://doi.org/10.3390/ijms20061314</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20061314</ArticleId></ArticleIdList></Reference><Reference><Citation>Halievski K, Xu Y, Haddad YW, Tang YP, Yamada S, Katsuno M, Adachi H, Sobue G, Breedlove SM, Jordan CL (2020) Muscle BDNF improves synaptic and contractile muscle strength in Kennedy&#x2019;s disease mice in a muscle-type specific manner. J Physiol 598:2719&#x2013;2739. https://doi.org/10.1113/JP279208</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP279208</ArticleId><ArticleId IdType="pubmed">32306402</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashizume A, Fischbeck KH, Pennuto M, Fratta P, Katsuno M (2020) Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA). J Neurol Neurosurg Psychiatry 91:1085&#x2013;1091. https://doi.org/10.1136/jnnp-2020-322949</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-322949</ArticleId><ArticleId IdType="pubmed">32934110</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrington J, Zhou YP, Bugianesi RM, Dulski PM, Feng Y, Warren VA, Smith MM, Kohler MG, Garsky VM, Sanchez M, Wagner M, Raphaelli K, Banerjee P, Ahaghotu C, Wunderler D, Priest BT, Mehl JT, Garcia ML, McManus OB, Kaczorowski GJ, Slaughter RS (2006) Blockers of the delayed-rectifier potassium current in pancreatic &#x3b2;-cells enhance glucose-dependent insulin secretion. Diabetes 55:1034&#x2013;1042. https://doi.org/10.2337/diabetes.55.04.06.db05-0788</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.55.04.06.db05-0788</ArticleId><ArticleId IdType="pubmed">16567526</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida M, Sahashi K, Kondo N, Nakatsuji H, Tohnai G, Tsutsumi Y, Noda S, Murakami A, Onodera K, Okada Y, Nakatochi M, Tsukagoshi Okabe Y, Shimizu S, Mizuno M, Adachi H, Okano H, Sobue G, Katsuno M (2019) Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy. Nat Commun 10:4262. https://doi.org/10.1038/s41467-019-12282-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12282-7</ArticleId><ArticleId IdType="pubmed">31537808</ArticleId><ArticleId IdType="pmc">6753158</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez Gardu&#xf1;o AM, Ju&#xe1;rez-Hern&#xe1;ndez LJ, Polanco MJ, Tosatto L, Michelatti D, Arosio D, Basso M, Pennuto M, Musio C (2017) Altered ionic currents and amelioration by IGF-1 and PACAP in motoneuron-derived cells modelling SBMA. Biophys Chem 229:68&#x2013;76. https://doi.org/10.1016/j.bpc.2017.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpc.2017.05.003</ArticleId><ArticleId IdType="pubmed">28511915</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston J, Forsythe ID, Kopp-Scheinpflug C (2010) Going native: voltage-gated potassium channels controlling neuronal excitability. J Physiol 588:3187&#x2013;3200. https://doi.org/10.1113/jphysiol.2010.191973</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2010.191973</ArticleId><ArticleId IdType="pubmed">20519310</ArticleId><ArticleId IdType="pmc">2976014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P, Kumar D, Jha SK, Jha NK, Ambasta RK (2016) Ion channels in neurological disorders. Adv Protein Chem Struct Biol 103:97&#x2013;136. https://doi.org/10.1016/bs.apcsb.2015.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.apcsb.2015.10.006</ArticleId><ArticleId IdType="pubmed">26920688</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77&#x2013;79. https://doi.org/10.1038/352077a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/352077a0</ArticleId><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung YM, Kang Y, Gao X, Xia F, Xie H, Sheu L, Tsuk S, Lotan I, Tsushima RG, Gaisano HY (2003) Syntaxin 1A binds to the cytoplasmic C terminus of Kv2.1 to regulate channel gating and trafficking. J Biol Chem 278:17532&#x2013;17538. https://doi.org/10.1074/jbc.M213088200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M213088200</ArticleId><ArticleId IdType="pubmed">12621036</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, Shakkottai VG, Albin RL (2019) Polyglutamine repeats in neurodegenerative diseases. Annu Rev Pathol 14:1&#x2013;27. https://doi.org/10.1146/annurev-pathmechdis-012418-012857</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathmechdis-012418-012857</ArticleId><ArticleId IdType="pubmed">30089230</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu PW, Bean BP (2014) Kv2 channel regulation of action potential repolarization and firing patterns in superior cervical ganglion neurons and hippocampal CA1 pyramidal neurons. J Neurosci 34:4786&#x2013;4800. https://doi.org/10.1523/JNEUROSCI.1925-13.2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1925-13.2014</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo L, Hu P, Miao C, Ma A, Wang T (2017) Clenbuterol attenuates hERG channel by promoting the mature channel degradation. Int J Toxicol 36:314&#x2013;324. https://doi.org/10.1177/1091581817710786</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1091581817710786</ArticleId><ArticleId IdType="pubmed">28535735</ArticleId></ArticleIdList></Reference><Reference><Citation>Lvov A, Chikvashvili D, Michaelevski I, Lotan I (2008) VAMP2 interacts directly with the N terminus of Kv2.1 to enhance channel inactivation. Pflugers Arch - Eur J Physiol 456:1121&#x2013;1136. https://doi.org/10.1007/s00424-008-0468-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-008-0468-7</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald PE, Wang G, Tsuk S, Dodo C, Kang Y, Tang L, Wheeler MB, Cattral MS, Lakey JRT, Salapatek AMF, Lotan I, Gaisano HY (2002) Synaptosome-associated protein of 25 kilodaltons modulates Kv2.1 voltage-dependent K+ channels in neuroendocrine islet &#x3b2;-cells through an interaction with the channel N terminus. Mol Endocrinol 16:2452&#x2013;2461. https://doi.org/10.1210/me.2002-0058</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/me.2002-0058</ArticleId><ArticleId IdType="pubmed">12403834</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantilla CB, Zhan W-Z, Sieck GC (2004) Neurotrophins improve neuromuscular transmission in the adult rat diaphragm. Muscle Nerve 29:381&#x2013;386. https://doi.org/10.1002/mus.10558</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10558</ArticleId><ArticleId IdType="pubmed">14981737</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Rojas VA, Jim&#xe9;nez-Gardu&#xf1;o AM, Michelatti D, Tosatto L, Marchioretto M, Arosio D, Basso M, Pennuto M, Musio C (2020) ClC-2-like chloride current alterations in a cell model of spinal and bulbar muscular atrophy, a polyglutamine disease. J Mol Neurosci 1&#x2013;13. https://doi.org/10.1007/s12031-020-01687-5</Citation></Reference><Reference><Citation>Matsuyama Z, Wakamori M, Mori Y, Kawakami H, Nakamura S, Imoto K (1999) Direct alteration of the P/Q-type Ca2+ channel property by polyglutamine expansion in spinocerebellar ataxia 6. J Neurosci 19(12):RC14. https://doi.org/10.1523/JNEUROSCI.19-12-J0004.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.19-12-J0004.1999</ArticleId><ArticleId IdType="pubmed">10366652</ArticleId><ArticleId IdType="pmc">6782654</ArticleId></ArticleIdList></Reference><Reference><Citation>Milioto C, Malena A, Maino E, Polanco MJ, Marchioretti C, Borgia D, Gomes Pereira M, Blaauw B, Lieberman AP, Venturini R, Plebani M, Sambataro F, Vergani L, Pegoraro E, Sorar&#xf9; G, Pennuto M (2017) Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes. Sci Rep 7:1&#x2013;14. https://doi.org/10.1038/srep41046</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41046</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda AS, Cardozo PL, Silva FR, de Souza JM, Olmo IG, Cruz JS, Gomez MV, Ribeiro FM, Vieira LB (2019) Alterations of calcium channels in a mouse model of Huntington&#x2019;s disease and neuroprotection by blockage of Ca<sub>V</sub>1 channels. ASN Neuro 11:1759091419856811. https://doi.org/10.1177/1759091419856811</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759091419856811</ArticleId><ArticleId IdType="pubmed">31216184</ArticleId><ArticleId IdType="pmc">6585245</ArticleId></ArticleIdList></Reference><Reference><Citation>Misonou H, Mohapatra DP, Park EW, Leung V, Zhen D, Misonou K, Anderson AE, Trimmer JS (2004) Regulation of ion channel localization and phosphorylation by neuronal activity. Nat Neurosci 7:711&#x2013;718. https://doi.org/10.1038/nn1260</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1260</ArticleId><ArticleId IdType="pubmed">15195093</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohapatra DP, Misonou H, Pan SJ, Held JE, Surmeier DJ, Trimmer JS (2009) Regulation of intrinsic excitability in hippocampal neurons by activity-dependent modulation of the KV2.1 potassium channel. Channels 3:46&#x2013;56. https://doi.org/10.4161/chan.3.1.7655</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/chan.3.1.7655</ArticleId><ArticleId IdType="pubmed">19276663</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura M, Mita S, Murakami T, Uchino M, Watanabe S, Tokunaga M, Kumamoto T, Ando M (1994) Exonic trinucleotide repeats and expression of androgen receptor gene in spinal cord from X-linked spinal and bulbar muscular atrophy. J Neurol Sci 122:74&#x2013;79. https://doi.org/10.1016/0022-510x(94)90054-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510x(94)90054-x</ArticleId><ArticleId IdType="pubmed">7515106</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath SR, Lieberman ML, Yu Z, Marchioretti C, Jones ST, Danby ECE, Van Pelt KM, Sorar&#xf9; G, Robins DM, Bates GP, Pennuto M, Lieberman AP (2020) MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease. Acta Neuropathol 140:63&#x2013;80. https://doi.org/10.1007/s00401-020-02156-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02156-4</ArticleId><ArticleId IdType="pubmed">32306066</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilius B, Carbone E (2014) Amazing T-type calcium channels: Updating functional properties in health and disease. Pflugers Arch - Eur J Physiol 466:623&#x2013;626. https://doi.org/10.1007/s00424-014-1481-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-014-1481-7</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connell KMS, Loftus R, Tamkun MM (2010) Localization-dependent activity of the Kv2.1 delayed-rectifier K<sup>+</sup> channel. Proc Natl Acad Sci USA 107:12351&#x2013;12356. https://doi.org/10.1073/pnas.1003028107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1003028107</ArticleId><ArticleId IdType="pubmed">20566856</ArticleId><ArticleId IdType="pmc">2901471</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshima N, Onimaru H, Yamamoto K, Takechi H, Nishida Y, Oda T, Kumagai H (2014) Expression and functions of &#x3b2;<sub>1</sub>- and &#x3b2;<sub>2</sub>-adrenergic receptors on the bulbospinal neurons in the rostral ventrolateral medulla. Hypertens Res 37:976&#x2013;983. https://doi.org/10.1038/hr.2014.112</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/hr.2014.112</ArticleId><ArticleId IdType="pubmed">24965172</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I, Stack C, Kong L, Musaro A, Adachi H, Katsuno M et al (2009) Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 63:316&#x2013;328. https://doi.org/10.1016/j.neuron.2009.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2009.07.019</ArticleId><ArticleId IdType="pubmed">19679072</ArticleId><ArticleId IdType="pmc">2735765</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennuto M, Basso M (2016) In vitro and in vivo modeling of spinal and bulbar muscular atrophy. J Mol Neurosci 58:365&#x2013;373. https://doi.org/10.1007/s12031-015-0677-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-015-0677-4</ArticleId><ArticleId IdType="pubmed">26614347</ArticleId></ArticleIdList></Reference><Reference><Citation>Polanco MJ, Parodi S, Piol D, Stack C, Chivet M, Contestabile A, Miranda HC, Lievens PMJ, Espinoza S, Jochum T, Rocchi A, Grunseich C, Gainetdinov RR, Cato ACB, Lieberman AP, La Spada AR, Sambataro F, Fischbeck KH, Gozes I, Pennuto M (2016) Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy. SciTransl Med 8:370ra181&#x2013;370ra181. https://doi.org/10.1126/scitranslmed.aaf9526</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf9526</ArticleId></ArticleIdList></Reference><Reference><Citation>Polo A, Teatini F, D&#x2019;Anna S, Manganotti P, Salviati A, Dallapiccola B, Zanette G, Rizzuto N (1996) Sensory involvement in X-linked spino-bulbar muscular atrophy (Kennedy&#x2019;s syndrome): an electrophysiological study. J Neurol 243:388&#x2013;392. https://doi.org/10.1007/BF00868997</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00868997</ArticleId><ArticleId IdType="pubmed">8741078</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, Bede P, Marchand-Pauvert V, Pradat PF (2018) Biomarkers of spinal and bulbar muscle atrophy (SBMA): a comprehensive review. Front Neurol 9:844. https://doi.org/10.3389/fneur.2018.00844</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00844</ArticleId><ArticleId IdType="pubmed">30364135</ArticleId><ArticleId IdType="pmc">6191472</ArticleId></ArticleIdList></Reference><Reference><Citation>Redman PT, He K, Hartnett KA, Jefferson BS, Hu L, Rosenberg PA, Levitan ES, Aizenman E (2007) Apoptotic surge of potassium currents is mediated by p38 phosphorylation of Kv2.1. Proc Natl Acad Sci USA 104:3568&#x2013;3573. https://doi.org/10.1073/pnas.0610159104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0610159104</ArticleId><ArticleId IdType="pubmed">17360683</ArticleId><ArticleId IdType="pmc">1805571</ArticleId></ArticleIdList></Reference><Reference><Citation>Regev N, Degani-Katzav N, Korngreen A, Etzioni A, Siloni S, Alaimo A, Chikvashvili D, Villarroel A, Attali B, Lotan I (2009) Selective interaction of syntaxin 1A with KCNQ2: possible implications for specific modulation of presynaptic activity. PLoS ONE 4:e6586. https://doi.org/10.1371/journal.pone.0006586</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0006586</ArticleId><ArticleId IdType="pubmed">19675672</ArticleId><ArticleId IdType="pmc">2721677</ArticleId></ArticleIdList></Reference><Reference><Citation>Romer SH, Deardorff AS, Fyffe REW (2019) A molecular rheostat: Kv2.1 currents maintain or suppress repetitive firing in motoneurons. J Physiol 597:3769&#x2013;3786. https://doi.org/10.1113/JP277833</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP277833</ArticleId><ArticleId IdType="pubmed">31145471</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosati B, McKinnon D (2004) Regulation of ion channel expression. Circ Res 94:874&#x2013;883. https://doi.org/10.1161/01.RES.0000124921.81025</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000124921.81025</ArticleId><ArticleId IdType="pubmed">15087427</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar-Grueso EF, Kim S, Kim H (1991) Embryonic mouse spinal cord motor neuron hybrid cells. NeuroReport 2:505&#x2013;508. https://doi.org/10.1097/00001756-199109000-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199109000-00002</ArticleId><ArticleId IdType="pubmed">1751804</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaramuzzino C, Casci I, Parodi S, Lievens PMJ, Polanco MJ, Milioto C, Chivet M, Monaghan J, Mishra A, Badders N, Aggarwal T, Grunseich C, Sambataro F, Basso M, Fackelmayer FO, Taylor JP, Pandey UB, Pennuto M (2015) Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy. Neuron 85:88&#x2013;100. https://doi.org/10.1016/j.neuron.2014.12.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.031</ArticleId><ArticleId IdType="pubmed">25569348</ArticleId><ArticleId IdType="pmc">4305189</ArticleId></ArticleIdList></Reference><Reference><Citation>Sculptoreanu A, Abramovici H, Abdullah AA, Bibikova A, Panet-Raymond V, Frankel D et al (2000) Increased T-type Ca<sup>2+</sup> channel activity as a determinant of cellular toxicity in neuronal cell lines expressing polyglutamine-expanded human androgen receptors. Mol Cell Biochem 203:23&#x2013;31. https://doi.org/10.1023/a:1007010020228</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1007010020228</ArticleId><ArticleId IdType="pubmed">10724329</ArticleId></ArticleIdList></Reference><Reference><Citation>Semkova I, Schilling M, Henrich-Noack P, Rami A, Krieglstein J (1996) Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res 717:44&#x2013;54. https://doi.org/10.1016/0006-8993(95)01567-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(95)01567-1</ArticleId><ArticleId IdType="pubmed">8738252</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma M, Flood PM (2018) Adrenergic receptors as pharmacological targets for neuroinflammation and neurodegeneration in Parkinson&#x2019;s disease. In: Neuroprotection (Chuen-Chung Chang R, Ho Y-S, eds) IntechOpen. https://doi.org/10.5772/intechopen.81343</Citation></Reference><Reference><Citation>Shepherd AJ, Loo L, Gupte RP, Mickle AD, Mohapatra DP (2012) Distinct modifications in Kv2.1 channel via chemokine receptor CXCR4 regulate neuronal survival-death dynamics. J Neurosci 32:17725&#x2013;17739. https://doi.org/10.1523/JNEUROSCI.3029-12.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3029-12.2012</ArticleId><ArticleId IdType="pubmed">23223293</ArticleId><ArticleId IdType="pmc">3544972</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya K, Misawa S, Uzawa A, Sawai S, Tsuneyama A, Suzuki YI, Suichi T, Kojima Y, Nakamura K, Kano H, Prado M, Kuwabara S (2020) Split hand and motor axonal hyperexcitability in spinal and bulbar muscular atrophy. J Neurol Neurosurg Psychiatry 91:1189&#x2013;1194. https://doi.org/10.1136/jnnp-2020-324026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-324026</ArticleId><ArticleId IdType="pubmed">32934003</ArticleId></ArticleIdList></Reference><Reference><Citation>Song MY, Hong C, Bae SH, So I, Park KS (2012) Dynamic modulation of the Kv2.1 channel by Src-dependent tyrosine phosphorylation. J Proteome Res 11:1018&#x2013;1026. https://doi.org/10.1021/pr200770v</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr200770v</ArticleId><ArticleId IdType="pubmed">22106938</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoyas CA, La Spada AR (2018) The CAG-polyglutamine repeat diseases: a clinical, molecular, genetic, and pathophysiologic nosology. Handb Clin Neurol 147:143&#x2013;170. https://doi.org/10.1016/B978-0-444-63233-3.00011-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63233-3.00011-7</ArticleId><ArticleId IdType="pubmed">29325609</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong X, Ao Y, Faas GC, Nwaobi SE, Xu J, Haustein MD, Anderson MA, Mody I, Olsen ML, Sofroniew MV, Khakh BS (2014) Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington&#x2019;s disease model mice. Nat Neurosci 17:694&#x2013;703. https://doi.org/10.1038/nn.3691</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3691</ArticleId><ArticleId IdType="pubmed">24686787</ArticleId><ArticleId IdType="pmc">4064471</ArticleId></ArticleIdList></Reference><Reference><Citation>Vismara G, Simonini F, Onesto E, Bignamini M, Miceli V, Martini L, Poletti A (2009) Androgens inhibit androgen receptor promoter activation in motor neurons. Neurobiol Dis 33:395&#x2013;404. https://doi.org/10.1016/j.nbd.2008.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.11.007</ArticleId><ArticleId IdType="pubmed">19100835</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters CW, Varuzhanyan G, Talmadge RJ, Voss AA (2013) Huntington disease skeletal muscle is hyperexcitable owing to chloride and potassium channel dysfunction. Proc Natl Acad Sci USA 110(22):9160&#x2013;9165. https://doi.org/10.1073/pnas.1220068110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1220068110</ArticleId><ArticleId IdType="pubmed">23671115</ArticleId><ArticleId IdType="pmc">3670332</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson JM, Rempel J, Brownstone RM (2004) Postnatal development of cholinergic synapses on mouse spinal motoneurons. J Comp Neurol 474:13&#x2013;23. https://doi.org/10.1002/cne.20089</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.20089</ArticleId><ArticleId IdType="pubmed">15156576</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf-Goldberg T, Michaelevski I, Sheu L, Gaisano HY, Chikvashvili D, Lotan I (2006) Target soluble N-ethylmaleimide-sensitive factor attachment protein receptors (t-SNARES) differently regulate activation and inactivation gating of Kv2.2 and Kv2.1: implications on pancreatic islet cell Kv channels. Mol Pharmacol 70:818&#x2013;828. https://doi.org/10.1124/mol.105.021717</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.105.021717</ArticleId><ArticleId IdType="pubmed">16754785</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Halievski K, Henley C, Atchison WD, Katsuno M, Adachi H, Sobue G, Marc Breedlove S, Jordan CL (2016) Defects in neuromuscular transmission may underlie motor dysfunction in spinal and bulbar muscular atrophy. J Neurosci 36:5094&#x2013;5106. https://doi.org/10.1523/JNEUROSCI.3485-15.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3485-15.2016</ArticleId><ArticleId IdType="pubmed">27147661</ArticleId><ArticleId IdType="pmc">4854970</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh CY, Ye Z, Moutal A, Gaur S, Henton AM, Kouvaros S, Saloman JL, Hartnett-Scott KA, Tzounopoulos T, Khanna R, Aizenman E, Camacho CJ (2019) Defining the Kv2.1-syntaxin molecular interaction identifies a first-in-class small molecule neuroprotectant. Proc Natl Acad Sci USA 116:15696&#x2013;15705. https://doi.org/10.1073/pnas.1903401116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1903401116</ArticleId><ArticleId IdType="pubmed">31308225</ArticleId><ArticleId IdType="pmc">6681760</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeman RJ, Peng H, Etlinger JD (2004) Clenbuterol retards loss of motor function in motor neuron degeneration mice. Exp Neurol 187:460&#x2013;467. https://doi.org/10.1016/j.expneurol.2004.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2004.03.006</ArticleId><ArticleId IdType="pubmed">15144872</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M-H, Yang G, Jiao S, Hu C-L, Mei Y-A (2012) Cholesterol enhances neuron susceptibility to apoptotic stimuli via cAMP/PKA/CREB-dependent up-regulation of Kv2.1. J Neurochem 120:502&#x2013;514. https://doi.org/10.1111/j.1471-4159.2011.07593.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07593.x</ArticleId><ArticleId IdType="pubmed">22118516</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang J-L, Wang C-Y, Zhou M-H, Duan K-Z, Mei Y-A (2012) TGF-&#x3b2;1 enhances Kv2.1 potassium channel protein expression and promotes maturation of cerebellar granule neurons. J Cell Physiol 227:297&#x2013;307. https://doi.org/10.1002/jcp.22735</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.22735</ArticleId><ArticleId IdType="pubmed">21412780</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>